ResearcherHospital Virgen de la SaludNo recent work listed
Antonio Irigoyen
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: 1 paper
Papers 6
- Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for identifying novel diagnostic biomarkers. Co-author DOI 10.1371/journal.pone.0194844↗
- Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety … Co-author DOI 10.1016/j.ejca.2016.12.032↗
- Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients. First author DOI 10.1016/j.taap.2016.10.003↗
- Prognosis Relevance of Serum Cytokines in Pancreatic Cancer. Co-author DOI 10.1155/2015/518284↗
- Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers. Co-author DOI 10.1007/s10620-014-3291-3↗
- Serum cytokine profile in patients with pancreatic cancer. Co-author DOI 10.1097/mpa.0000000000000155↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Carolina Torres · 5 shared papers, 2014–2018 · strength 0.25
- Paper Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for i… DOI 10.1371/journal.pone.0194844↗
- Paper Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinom… DOI 10.1016/j.taap.2016.10.003↗
- Paper Prognosis Relevance of Serum Cytokines in Pancreatic Cancer. DOI 10.1155/2015/518284↗
- Jose Carlos Prados · 5 shared papers, 2014–2018 · strength 0.25
- Paper Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for i… DOI 10.1371/journal.pone.0194844↗
- Paper Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinom… DOI 10.1016/j.taap.2016.10.003↗
- Paper Prognosis Relevance of Serum Cytokines in Pancreatic Cancer. DOI 10.1155/2015/518284↗
- Octavio Caba · 4 shared papers, 2014–2018 · strength 0.20
- Paper Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for i… DOI 10.1371/journal.pone.0194844↗
- Paper Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinom… DOI 10.1016/j.taap.2016.10.003↗
- Paper Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers. DOI 10.1007/s10620-014-3291-3↗
- Manuel Benavides · 3 shared papers, 2016–2018 · strength 0.18
- Paper Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for i… DOI 10.1371/journal.pone.0194844↗
- Paper Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinom… DOI 10.1016/j.taap.2016.10.003↗
- Paper Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic… DOI 10.1016/j.ejca.2016.12.032↗
- Javier Gallego-Plazas · 3 shared papers, 2016–2018 · strength 0.18
- Paper Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for i… DOI 10.1371/journal.pone.0194844↗
- Paper Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinom… DOI 10.1016/j.taap.2016.10.003↗
- Paper Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic… DOI 10.1016/j.ejca.2016.12.032↗
- Carmen Guillén‐Ponce · 3 shared papers, 2016–2018 · strength 0.18
- Paper Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for i… DOI 10.1371/journal.pone.0194844↗
- Paper Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinom… DOI 10.1016/j.taap.2016.10.003↗
- Paper Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic… DOI 10.1016/j.ejca.2016.12.032↗
- Enrique Aranda · 3 shared papers, 2016–2018 · strength 0.18
- Paper Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for i… DOI 10.1371/journal.pone.0194844↗
- Paper Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinom… DOI 10.1016/j.taap.2016.10.003↗
- Paper Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic… DOI 10.1016/j.ejca.2016.12.032↗
- Cristina Jiménez‐Luna · 3 shared papers, 2014–2018 · strength 0.17
- Paper Integrative multi-platform meta-analysis of gene expression profiles in pancreatic ductal adenocarcinoma patients for i… DOI 10.1371/journal.pone.0194844↗
- Paper Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinom… DOI 10.1016/j.taap.2016.10.003↗
- Paper Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers. DOI 10.1007/s10620-014-3291-3↗
- Antonia Aránega · 3 shared papers, 2014–2015 · strength 0.12
- Paper Prognosis Relevance of Serum Cytokines in Pancreatic Cancer. DOI 10.1155/2015/518284↗
- Paper Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers. DOI 10.1007/s10620-014-3291-3↗
- Paper Serum cytokine profile in patients with pancreatic cancer. DOI 10.1097/mpa.0000000000000155↗
- Sonia Perales · 3 shared papers, 2014–2015 · strength 0.12
- Paper Prognosis Relevance of Serum Cytokines in Pancreatic Cancer. DOI 10.1155/2015/518284↗
- Paper Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers. DOI 10.1007/s10620-014-3291-3↗
- Paper Serum cytokine profile in patients with pancreatic cancer. DOI 10.1097/mpa.0000000000000155↗
- Ana Linares · 3 shared papers, 2014–2015 · strength 0.12
- Paper Prognosis Relevance of Serum Cytokines in Pancreatic Cancer. DOI 10.1155/2015/518284↗
- Paper Transcriptional profiling of peripheral blood in pancreatic adenocarcinoma patients identifies diagnostic biomarkers. DOI 10.1007/s10620-014-3291-3↗
- Paper Serum cytokine profile in patients with pancreatic cancer. DOI 10.1097/mpa.0000000000000155↗
- Joaquina Martínez-Galán · 2 shared papers, 2015–2017 · strength 0.09
- Fernando Rivera · 1 shared paper, 2017 · strength 0.05
- José Luis Manzano Mozo · 1 shared paper, 2017 · strength 0.05
- Ruth Vera · 1 shared paper, 2017 · strength 0.05
- Marta Martín-Richard · 1 shared paper, 2017 · strength 0.05
- Roberto Pazo-Cid · 1 shared paper, 2017 · strength 0.05
- Raúl Ortíz · 1 shared paper, 2014 · strength 0.04
- Consolación Melguizo · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.